Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conrad J Wong

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Behavior Modification|January 20, 2005
A web-based therapeutic workplace for the treatment of drug addiction and chronic unemploymentKenneth Silverman, Conrad J Wong, Michael J Grabinski, et al.
Journal of Applied Behavior Analysis|November 1, 2007
A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug usersKenneth Silverman, Conrad J Wong, Mick Needham, et al.
Drug and Alcohol Dependence|December 4, 2012
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trialSharon L Walsh, Lisa S Middleton, Conrad J Wong, et al.
Drug and Alcohol Dependence|July 21, 2009
An internet-based abstinence reinforcement smoking cessation intervention in rural smokersWilliam W Stoops, Jesse Dallery, Nell M Fields, et al.
Archives of General Psychiatry|October 15, 2003
Community reinforcement therapy for cocaine-dependent outpatientsStephen T Higgins, Stacey C Sigmon, Conrad J Wong, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 31, 2011
A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adultsMikhail N Koffarnus, Conrad J Wong, Karly Diemer, et al.
Alcoholism, Clinical and Experimental Research|July 21, 2016
Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol DependenceAnke Post, Trevor S Smart, Kimberley Jackson, et al.
Journal of Clinical Pharmacology|March 13, 2014
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjectsStephen L Lowe, Conrad J Wong, Jennifer Witcher, et al.
Alcoholism, Clinical and Experimental Research|September 10, 2013
A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependenceConrad J Wong, Jennifer Witcher, Craig Mallinckrodt, et al.
Alcoholism, Clinical and Experimental Research|April 17, 2016
A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal ModelsLinda M Rorick-Kehn, Roberto Ciccocioppo, Conrad J Wong, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Behavior Modification|January 20, 2005
A web-based therapeutic workplace for the treatment of drug addiction and chronic unemploymentKenneth Silverman, Conrad J Wong, Michael J Grabinski, et al.
Journal of Applied Behavior Analysis|November 1, 2007
A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug usersKenneth Silverman, Conrad J Wong, Mick Needham, et al.
Drug and Alcohol Dependence|December 4, 2012
Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trialSharon L Walsh, Lisa S Middleton, Conrad J Wong, et al.
Drug and Alcohol Dependence|July 21, 2009
An internet-based abstinence reinforcement smoking cessation intervention in rural smokersWilliam W Stoops, Jesse Dallery, Nell M Fields, et al.
Archives of General Psychiatry|October 15, 2003
Community reinforcement therapy for cocaine-dependent outpatientsStephen T Higgins, Stacey C Sigmon, Conrad J Wong, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 31, 2011
A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adultsMikhail N Koffarnus, Conrad J Wong, Karly Diemer, et al.
Alcoholism, Clinical and Experimental Research|July 21, 2016
Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol DependenceAnke Post, Trevor S Smart, Kimberley Jackson, et al.
Journal of Clinical Pharmacology|March 13, 2014
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjectsStephen L Lowe, Conrad J Wong, Jennifer Witcher, et al.
Alcoholism, Clinical and Experimental Research|September 10, 2013
A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependenceConrad J Wong, Jennifer Witcher, Craig Mallinckrodt, et al.
Alcoholism, Clinical and Experimental Research|April 17, 2016
A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal ModelsLinda M Rorick-Kehn, Roberto Ciccocioppo, Conrad J Wong, et al.
Pageof 4